NASDAQ:KURA

Kura Oncology Stock Insider Trading

etoro logo Buy KURA
*Your capital is at risk
$10.38
+0.0200 (+0.193%)
At Close: Jun 23, 2026

Kura Oncology Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 19.04. In total, the insiders bought 4.12M and sold 370.31K KURA shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
19.04
Buy 4.12M shares
Sell 370.31K shares
60% Buy Activity
Moderate Negative Correlation
Sell Signal Low Confidence
Jun 18, 2026

Analysis Breakdown:

  • Weakened by a contradictory positive Insider Power Score.
  • Partially supported by a negative historical correlation.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Jun 18, 2026
Sell
Common Stock
S-Sale
Leoni Mollie
Chief Medical Officer
Officer 84 929
Value: $834.3K
Jun 04, 2026
Buy
Option to purchase common stock
A-Award
Malley Thomas
Director
Director 35 000
Value: $307.0K
Jun 04, 2026
Buy
Option to purchase common stock
A-Award
Schafer Carol
Director
Director 35 000
Value: $307.0K
Jun 04, 2026
Buy
Option to purchase common stock
A-Award
Collins Helen Louise
Director
Director 35 000
Value: $307.0K
Jun 04, 2026
Buy
Option to purchase common stock
A-Award
Parks Diane L.
Director
Director 35 000
Value: $307.0K
Jun 04, 2026
Buy
Option to purchase common stock
A-Award
Vasconcelles Michael
Director
Director 35 000
Value: $307.0K
Jun 04, 2026
Buy
Option to purchase common stock
A-Award
Hasnain Faheem
Director
Director 35 000
Value: $307.0K
Jun 04, 2026
Buy
Option to purchase common stock
A-Award
Szela Mary T
Director
Director 35 000
Value: $307.0K
May 21, 2026
Sell
Common Stock
S-Sale
Powl Brian T.
Chief Commercial Officer
Officer 10 000
Value: $110.0K
May 19, 2026
Sell
Common Stock
S-Sale
Powl Brian T.
Chief Commercial Officer
Officer 339
Value: $3K
May 19, 2026
Sell
Common Stock
S-Sale
Ford Kathleen
Chief Operating Officer
C-Suite Officer 2 257
Value: $20.5K
May 18, 2026
Sell
Common Stock
S-Sale
Bair Teresa Brophy
Chief Legal Officer
Officer 2 256
Value: $21.2K
Mar 23, 2026
Buy
Stock Option (Right to Buy)
M-Exempt
Wilson Troy Edward
President And CEO
CEO / President 6 103
Value: $37.5K
Mar 23, 2026
Buy
Common Stock
M-Exempt
Wilson Troy Edward
President And CEO
CEO / President 6 103
Value: $37.5K
Mar 18, 2026
Buy
Stock Option (Right to Buy)
M-Exempt
Malley Thomas
Director
Director 10 000
Value: $31.2K
Mar 18, 2026
Buy
Common Stock
M-Exempt
Malley Thomas
Director
Director 10 000
Value: $31.2K
Jan 27, 2026
Sell
Common Stock
S-Sale
Bair Teresa Brophy
Chief Legal Officer
Officer 4 777
Value: $40.4K
Jan 27, 2026
Sell
Common Stock
S-Sale
Bair Teresa Brophy
Chief Legal Officer
Officer 2 335
Value: $19.8K
Jan 27, 2026
Sell
Common Stock
S-Sale
Bair Teresa Brophy
Chief Legal Officer
Officer 4 096
Value: $34.7K
Jan 27, 2026
Sell
Common Stock
S-Sale
Burrows Francis
Chief Scientific Officer
Officer 1 311
Value: $11.1K
Jan 27, 2026
Sell
Common Stock
S-Sale
Doyle Thomas James
SVP, Finance & Accounting
Officer 881
Value: $7K
Jan 27, 2026
Sell
Common Stock
S-Sale
Doyle Thomas James
SVP, Finance & Accounting
Officer 2 226
Value: $18.8K
Jan 27, 2026
Sell
Common Stock
S-Sale
Doyle Thomas James
SVP, Finance & Accounting
Officer 695
Value: $6K
Jan 27, 2026
Sell
Common Stock
S-Sale
Doyle Thomas James
SVP, Finance & Accounting
Officer 2 226
Value: $18.8K
Jan 27, 2026
Sell
Common Stock
S-Sale
Leoni Mollie
Chief Medical Officer
Officer 1 341
Value: $11.3K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT KURA ONCOLOGY
Kura Oncology
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A protein-protein interaction for the treatment of genetically defined subsets of acute leukemias, includi...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
18.12% Jun 12
DHI
$146.71
6.39% Jun 10
E
ETD
$20.67
4.79% Jun 05
EAT
$140.46
16.94% Jun 05
TPR
$140.47
7.16% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE